Doxorubicin	doxorubicin	S_chemical	O
cardiomyopathy-induced	cardiomyopathy-induced	O	O
inflammation	inflammation	O	S_disease
and	and	O	O
apoptosis	apoptosis	O	O
are	are	O	O
attenuated	attenuated	O	O
by	by	O	O
gene	gene	O	O
deletion	deletion	O	O
of	of	O	O
the	the	O	O
kinin	kinin	O	O
B1	b1	O	O
receptor	receptor	O	O
.	.	O	O

Clinical	clinical	O	O
use	use	O	O
of	of	O	O
the	the	O	O
anthracycline	anthracycline	S_chemical	O
doxorubicin	doxorubicin	S_chemical	O
(	(	O	O
DOX	dox	S_chemical	O
)	)	O	O
is	is	O	O
limited	limited	O	O
by	by	O	O
its	its	O	O
cardiotoxic	cardiotoxic	O	S_disease
effects	effects	O	O
,	,	O	O
which	which	O	O
are	are	O	O
attributed	attributed	O	O
to	to	O	O
the	the	O	O
induction	induction	O	O
of	of	O	O
apoptosis	apoptosis	O	O
.	.	O	O

To	to	O	O
elucidate	elucidate	O	O
the	the	O	O
possible	possible	O	O
role	role	O	O
of	of	O	O
the	the	O	O
kinin	kinin	O	O
B1	b1	O	O
receptor	receptor	O	O
(	(	O	O
B1R	b1r	O	O
)	)	O	O
during	during	O	O
the	the	O	O
development	development	O	O
of	of	O	O
DOX	dox	S_chemical	O
cardiomyopathy	cardiomyopathy	O	S_disease
,	,	O	O
we	we	O	O
studied	studied	O	O
B1R	b1r	O	O
knockout	knockout	O	O
mice	mice	O	O
(	(	O	O
B1R(-/-	b1r(-/-	O	O
)	)	O	O
)	)	O	O
by	by	O	O
investigating	investigating	O	O
cardiac	cardiac	O	O
inflammation	inflammation	O	S_disease
and	and	O	O
apoptosis	apoptosis	O	O
after	after	O	O
induction	induction	O	O
of	of	O	O
DOX-induced	dox-induced	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
.	.	O	O

DOX	dox	S_chemical	O
control	control	O	O
mice	mice	O	O
showed	showed	O	O
cardiac	cardiac	O	B_disease
dysfunction	dysfunction	O	I_disease
measured	measured	O	O
by	by	O	O
pressure-volume	pressure-volume	O	O
loops	loops	O	O
in	in	O	O
vivo	vivo	O	O
.	.	O	O

This	this	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
a	a	O	O
reduced	reduced	O	O
activation	activation	O	O
state	state	O	O
of	of	O	O
AKT	akt	O	O
,	,	O	O
as	as	O	O
well	well	O	O
as	as	O	O
an	an	O	O
increased	increased	O	O
bax/bcl2	bax/bcl2	O	O
ratio	ratio	O	O
in	in	O	O
Western	western	O	O
blots	blots	O	O
,	,	O	O
indicating	indicating	O	O
cardiac	cardiac	O	O
apoptosis	apoptosis	O	O
.	.	O	O

Furthermore	furthermore	O	O
,	,	O	O
mRNA	mrna	O	O
levels	levels	O	O
of	of	O	O
the	the	O	O
proinflammatory	proinflammatory	O	O
cytokine	cytokine	O	O
interleukin	interleukin	O	O
6	6	O	O
were	were	O	O
increased	increased	O	O
in	in	O	O
the	the	O	O
cardiac	cardiac	O	O
tissue	tissue	O	O
.	.	O	O

In	in	O	O
DOX	dox	S_chemical	O
B1R(-/-	b1r(-/-	O	O
)	)	O	O
mice	mice	O	O
,	,	O	O
cardiac	cardiac	O	B_disease
dysfunction	dysfunction	O	I_disease
was	was	O	O
improved	improved	O	O
compared	compared	O	O
to	to	O	O
DOX	dox	S_chemical	O
control	control	O	O
mice	mice	O	O
,	,	O	O
which	which	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
normalization	normalization	O	O
of	of	O	O
the	the	O	O
bax/bcl-2	bax/bcl-2	O	O
ratio	ratio	O	O
and	and	O	O
interleukin	interleukin	O	O
6	6	O	O
,	,	O	O
as	as	O	O
well	well	O	O
as	as	O	O
AKT	akt	O	O
activation	activation	O	O
state	state	O	O
.	.	O	O

These	these	O	O
findings	findings	O	O
suggest	suggest	O	O
that	that	O	O
B1R	b1r	O	O
is	is	O	O
detrimental	detrimental	O	O
in	in	O	O
DOX	dox	S_chemical	O
cardiomyopathy	cardiomyopathy	O	S_disease
in	in	O	O
that	that	O	O
it	it	O	O
mediates	mediates	O	O
the	the	O	O
inflammatory	inflammatory	O	O
response	response	O	O
and	and	O	O
apoptosis	apoptosis	O	O
.	.	O	O

These	these	O	O
insights	insights	O	O
might	might	O	O
have	have	O	O
useful	useful	O	O
implications	implications	O	O
for	for	O	O
future	future	O	O
studies	studies	O	O
utilizing	utilizing	O	O
B1R	b1r	O	O
antagonists	antagonists	O	O
for	for	O	O
treatment	treatment	O	O
of	of	O	O
human	human	O	O
DOX	dox	S_chemical	O
cardiomyopathy	cardiomyopathy	O	S_disease
.	.	O	O

